SHANGHAI, May 6 (Reuters) - Shares in Chinese vaccine makers slumped on Thursday after U.S. President Joe Biden's support for a proposed waiver of intellectual property rights on COVID-19...
- Day's Range
- 50.05 - 51.38
- 52 wk Range
- 36.67 - 91.69
- Prev. Close
- Average Vol.(3m)
- 1-Year Change
- Market Cap
- P/E Ratio
- Shares Outstanding
- Dividend (Yield)
- 0.43 (0.85%)
- Next Earnings Date
- Mar 29, 2022
March 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS 2196.HK :* SAYS 2020 NET PROFIT UP 10.3% Y/Y* SAYS IT AUTHORISE UNIT GLAND PHARMA TO INVEST IN MUTUAL FUNDS AND...
(Adds book runners, analyst quote)By Anuron Kumar MitraBENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS got off to a flying start in their market debut on Friday,...
(Corrects amount raised in IPO to "64.80 billion rupees" from "73.87 billion rupees" in paragraph 1)BENGALURU, Nov 20 (Reuters) - Shares of India's Gland Pharma GLAD.NS rose as much as 20%...
By Rocky Swift, Sangmi Cha and Neil Jerome MoralesTOKYO/SEOUL/MANILA, Nov 10 (Reuters) - With tropical heat, remote island communities and a dearth of ultra-cold freezers, many Asian...
By Aditya Raghunath Investing.com -- India’s largest pharma IPO (initial public offering) received a very tepid response on day 1 as retail investors only subscribed 1.4% of the total...
BRIEF-Shanghai Fosun Pharma's Unit Gland Pharma Plans Listing In India's NSE And Bombay Stock Exchange
Nov 1 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 2196.HK 600196.SS :* SAYS UNIT GLAND PHARMA LTD PLANS LISTING IN INDIA'S NSE AND BOMBAY STOCK EXCHANGE
Investing.com – China equities were higher at the close on Monday, as gains in the Travel & Leisure, Real Estate Investments & Services and Technology Hardware & Equipment sectors propelled...
(Adds DP World, Walgreens Boots Alliance, Jollibee Foods , Ford Motor, Blackstone (NYSE:BX), Itron, Teva Pharmaceutical, Fir Tree Partners, Triton Knoll, Northrop Grumman ; Updates OHL ...
(Recasts, adds Gland Pharma comments, background) By Dominique Patton and Zeba Siddiqui BEIJING/MUMBAI, Sept 17 (Reuters) - Shanghai Fosun Pharmaceutical Group 600196.SS has agreed to cut...
BEIJING, Sept 17 (Reuters) - Shanghai Fosun Pharmaceutical Group 600196.SS has agreed to cut the size of the stake it will buy in India's Gland Pharma to 74 percent, the Chinese...
(Adds Indian statement in paragraphs 6-7) By Ben Blanchard BEIJING, Aug 3 (Reuters) - China is taking an increasingly tough line on a border row with India amid a rising crescendo of...
By Ben Blanchard BEIJING, Aug 3 (Reuters) - China is taking an increasingly tough line on a border row with India amid a rising crescendo of nationalism in state media, and President Xi...
* Deal has FIPB, CCI approval; CCEA nod pending * Fosun says closing date of deal extended to Sept. 26 (Releads to change source and add details) July 31 (Reuters) - India has privately...
March 30 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS : * Reference is made to announcements of Shanghai Fosun Pharmaceutical (Group) Co., dated 28 July 2016 *...
(Adds financing details) By Patricia Weiss and Claire Ruckin FRANKFURT/LONDON, March 15 (Reuters) - Two private equity consortia vying for control of German generic drugmaker Stada...
By Patricia Weiss and Alexander Hübner FRANKFURT, March 15 (Reuters) - The two private equity consortia vying for Stada STAGn.DE have made binding takeover offers each worth 4.7...
(Writes through with context) By Arno Schuetze and Sumeet Chatterjee FRANKFURT/HONG KONG, March 9 (Reuters) - China's Shanghai Fosun Pharmaceutical 600196.SS is planning a bid for German...
( Adds Brookdale Senior Living and UBI; Updates Mitsubishi Rayon, Valeant Pharmaceuticals and American Apparel) Jan 10 (Reuters) - The following bids, mergers, acquisitions and disposals...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.